The goal of this research program is to identify metabolomic characteristics that underpin the biological functions of rare populations of immune cells to facilitate the development of targeted clinical therapies.  With the support of a recent CBRF grant, Dalhousie is set to significantly upgrade its research capacity through acquisition of a state-of-the-art UPLC-MS system

Please Note: To ensure the latest information and updates regarding this bid, the onus is on the bidder to ensure they are monitoring the bidding system for issued addenda, clarifications and instructions that may impact submissions.